Description

The vaccine is a scientific result of Cuban biotechnology, of great international prestige, with excellent benefits in Cuban patients and in many other countries.

Treatment with Vaxira® allows controlling the growth of the tumor and increases the person’s life expectancy. It also improves the quality of life and the symptoms of the disease, making the patient feel physically and emotionally better.

The treatment requires admission with a companion. It is administered subcutaneously. It consists of an induction phase in which five doses are applied (one every 14 days) and a second maintenance phase that includes re-immunizations every 28 days, which will be maintained until the patient’s condition allows it.

In the Cuban oncology services that offer this program, the patient is evaluated by multidisciplinary teams (nationally certified and internationally endorsed) made up of internists, radiologists, pathologists, hematologists, surgeons, among others, presided over by a clinical oncologist. These specialists are responsible for establishing personalized treatment according to the diagnosis and stage of the cancer.